Literature DB >> 2562138

Differential systemic and regional hemodynamic profiles of four angiotensin-I converting-enzyme inhibitors in the rat.

C Richer1, M P Doussau, J F Giudicelli.   

Abstract

Angiotensin-converting enzyme (ACE) inhibitors decrease blood pressure by reducing systemic vascular resistance. That the peripheral vasodilating properties of ACE inhibitors might not be homogeneously distributed in all vascular beds and might differ from one drug to another has been investigated in the normotensive rat by the pulsed Doppler technique using the active components of four different ACE inhibitors: captopril, enalapril, perindopril, and ramipril. Systemic (cardiac output and blood pressure) and regional (kidney, mesentery, hindquarter) hemodynamic responses to saline or to cumulative bolus injections (0.01-1 mg/kg) of captopril, enalaprilat, perindoprilat, or ramiprilat were continuously monitored. The effects of successive bolus injections (0.3-300 ng/kg) of angiotensinII were also investigated. The four ACE inhibitors produced an almost complete blockade of plasma angiotensin-II converting-enzyme activity (83%, 100%, 100%, and 100%, respectively), induced dose-dependent decreases in mean blood pressure, did not significantly affect cardiac output, and reduced total peripheral and mesenteric vascular resistances to the same extent. Hindlimb vascular resistance was identically decreased, but to a lower extent than total peripheral resistance by enalaprilat, perindoprilat, and ramiprilat, whereas it was increased by captopril at low doses only. Renal resistance was markedly decreased by the four drugs, and especially by captopril. The decreasing rank order for ACE-inhibitor-induced vasodilation is exactly the same (renal greater than total peripheral = mesenteric greater than hindlimb vascular resistances) as that of angiotensin-H-induced regional vasoconstriction, indicating that the vasodilator properties of ACE inhibitors are mainly due to angiotensin-II vasomotor tone suppression. None of the investigated compounds significantly affected mesenteric and hindlimb blood flows, except captopril, which lowered the latter significantly.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2562138     DOI: 10.1007/BF01869574

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  20 in total

1.  Antihypertensive action of the converting enzyme inhibitor perindopril (S9490-3) in spontaneously hypertensive rats: comparison with enalapril (MK421) and ramipril (Hoe498).

Authors:  T Unger; M Moursi; D Ganten; K Hermann; R E Lang
Journal:  J Cardiovasc Pharmacol       Date:  1986 Mar-Apr       Impact factor: 3.105

Review 2.  Pharmacology of angiotensin.

Authors:  D Regoli; W K Park; F Rioux
Journal:  Pharmacol Rev       Date:  1974-06       Impact factor: 25.468

3.  An ultrasonic pulsed Doppler system for measuring blood flow in small vessels.

Authors:  C J Hartley; J S Cole
Journal:  J Appl Physiol       Date:  1974-10       Impact factor: 3.531

4.  Effects of captopril and enalapril on regional vascular resistance and reactivity in spontaneously hypertensive rats.

Authors:  C Richer; M P Doussau; J F Giudicelli
Journal:  Hypertension       Date:  1983 May-Jun       Impact factor: 10.190

5.  Graded regional vasodilation with converting enzyme inhibitors in conscious spontaneously hypertensive rats.

Authors:  R W Lappe; J A Todt; R L Wendt
Journal:  J Pharmacol Exp Ther       Date:  1985-12       Impact factor: 4.030

6.  Effects of acute and chronic angiotensin-converting enzyme inhibition on large arteries in human hypertension.

Authors:  A C Simon; J A Levenson; J Bouthier; B Maarek; M E Safar
Journal:  J Cardiovasc Pharmacol       Date:  1985       Impact factor: 3.105

7.  Increased aortic PGI2 and plasma lyso-PAF in the unclipped one-kidney hypertensive rat.

Authors:  H M McGowan; R Vandongen; J P Codde; K D Croft
Journal:  Am J Physiol       Date:  1986-12

8.  Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects.

Authors:  M Laubie; P Schiavi; M Vincent; H Schmitt
Journal:  J Cardiovasc Pharmacol       Date:  1984 Nov-Dec       Impact factor: 3.105

9.  Effects of angiotensin, vasopressin, and methoxamine on cardiac function and blood flow distribution in conscious dogs.

Authors:  G R Heyndrickx; D H Boettcher; S F Vatner
Journal:  Am J Physiol       Date:  1976-11

10.  Regional blood flow measurement with pulsed Doppler flowmeter in conscious rat.

Authors:  J R Haywood; R A Shaffer; C Fastenow; G D Fink; M J Brody
Journal:  Am J Physiol       Date:  1981-08
View more
  2 in total

1.  Effects of combined neutral endopeptidase 24-11 and angiotensin-converting enzyme inhibition on femoral vascular conductance in streptozotocin-induced diabetic rats.

Authors:  V Arbin; N Claperon; M C Fournié-Zaluski; B P Roques; J Peyroux
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

2.  Chronic vasodilation increases renal medullary PDE5A and α-ENaC through independent renin-angiotensin-aldosterone system pathways.

Authors:  Crystal A West; Stefan Shaw; Jennifer M Sasser; Andrea Fekete; Tyler Alexander; Mark W Cunningham; Shyama M E Masilamani; Chris Baylis
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-09-25       Impact factor: 3.619

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.